| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $183 to $225.
																	Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $16...
																	UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $185 to $220.
																	Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price ta...
																	MTG "buys the dip" on Netflix (NFLX) stock after a bad Q3 report. See all 14 of her new purchases, including MSFT and A...
																	Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...
																	Cardinal Health shares rise as Q1 earnings beat estimates, revenue jumps 22%, and the company lifts its 2026 earnings and cash ...